{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:10:01Z","timestamp":1777997401028,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.tranon.2025.102418","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:29:50Z","timestamp":1748971790000},"page":"102418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Dual action of pyrimidine derivatives: Targeting tamoxifen resistance in breast cancer"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5209-3874","authenticated-orcid":false,"given":"Jie","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6879-7835","authenticated-orcid":false,"given":"Narasimha M.","family":"Beeraka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Ravish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunachalam","family":"Chinnathambi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sulaiman Ali","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanchugarakoppal S.","family":"Rangappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir N.","family":"Nikolenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basappa","family":"Basappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.tranon.2025.102418_bib0001","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.3390\/cancers15194689","article-title":"Estrogen receptor signaling in breast cancer","volume":"15","author":"Miziak","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.tranon.2025.102418_bib0002","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13058-024-01895-6","article-title":"Deep learning applications in breast cancer histopathological imaging: diagnosis, treatment, and prognosis","volume":"26","author":"Jiang","year":"2024","journal-title":"Breast. Cancer Res."},{"issue":"9","key":"10.1016\/j.tranon.2025.102418_bib0003","doi-asserted-by":"crossref","first-page":"731","DOI":"10.20892\/j.issn.2095-3941.2024.0222","article-title":"Evolving molecular subtyping of breast cancer advances precision treatment","volume":"21","author":"Shan","year":"2024","journal-title":"Cancer Biol. Med."},{"issue":"17","key":"10.1016\/j.tranon.2025.102418_bib0004","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1158\/1078-0432.CCR-24-0244","article-title":"Computational model predicts patient outcomes in luminal B breast cancer treated with endocrine therapy and CDK4\/6 inhibition","volume":"30","author":"Schmiester","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.tranon.2025.102418_bib0005","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41419-024-06814-3","article-title":"Targeting LINC00152 activates cAMP\/Ca(2+)\/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer","volume":"15","author":"Saatci","year":"2024","journal-title":"Cell Death. Dis."},{"issue":"4","key":"10.1016\/j.tranon.2025.102418_bib0006","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/cas.14813","article-title":"HMGB1 is a key factor for tamoxifen resistance and has the potential to predict the efficacy of CDK4\/6 inhibitors in breast cancer","volume":"112","author":"Zhang","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tranon.2025.102418_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121986","article-title":"2D-CuPd nanozyme overcome tamoxifen resistance in breast cancer by regulating the PI3K\/AKT\/mTOR pathway","volume":"294","author":"Jiang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.tranon.2025.102418_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1390992","article-title":"Discovery of oxazine-linked pyrimidine as an inhibitor of breast cancer growth and metastasis by abrogating NF-kappaB activation","volume":"14","author":"Yuan","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2025.102418_bib0009","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41420-018-0026-9","article-title":"Sotetsuflavone suppresses invasion and metastasis in non-small-cell lung cancer A549 cells by reversing EMT via the TNF-alpha\/NF-kappaB and PI3K\/AKT signaling pathway","volume":"4","author":"Wang","year":"2018","journal-title":"Cell Death. Discov."},{"issue":"3","key":"10.1016\/j.tranon.2025.102418_bib0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3892\/ijo.2023.5553","article-title":"IGJ suppresses breast cancer growth and metastasis by inhibiting EMT via the NF\u2011kappaB signaling pathway","volume":"63","author":"Wang","year":"2023","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.tranon.2025.102418_bib0011","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/iub.2913","article-title":"Pyrimidine-triazole-tethered tert-butyl-piperazine-carboxylate suppresses breast cancer by targeting estrogen receptor signaling and beta-catenin activation","volume":"76","author":"Yuan","year":"2024","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.tranon.2025.102418_bib0012","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bmcl.2018.11.022","article-title":"Identification of novel triazole inhibitors of wnt\/beta-catenin signaling based on the Niclosamide chemotype","volume":"29","author":"Mook","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.tranon.2025.102418_bib0013","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1021\/acs.jmedchem.8b01408","article-title":"Triazole-based inhibitors of the wnt\/beta-catenin signaling pathway improve glucose and lipid metabolisms in diet-induced obese mice","volume":"62","author":"Obianom","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tranon.2025.102418_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1015428","article-title":"LncRNA SNHG6 sponges miR-101 and induces tamoxifen resistance in breast cancer cells through induction of EMT","volume":"12","author":"Khan","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102418_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13058-015-0579-y","volume":"17","author":"Yuan","year":"2015","journal-title":"Breast. Cancer Res."},{"key":"10.1016\/j.tranon.2025.102418_bib0016","article-title":"Effect of micropillar density on morphology and migration of low and high metastatic potential breast cancer cells","volume":"245","author":"Molinares","year":"2024","journal-title":"Colloids. Surf. B Biointerfaces."},{"issue":"9","key":"10.1016\/j.tranon.2025.102418_bib0017","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/onc.2012.128","article-title":"Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer","volume":"32","author":"Ward","year":"2013","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.tranon.2025.102418_bib0018","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13058-024-01876-9","article-title":"A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer","volume":"26","author":"Omar","year":"2024","journal-title":"Breast. Cancer Res."},{"issue":"10","key":"10.1016\/j.tranon.2025.102418_bib0019","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.3390\/biomedicines11102716","article-title":"Development of piperazine- and oxazine-linked pyrimidines as p65 subunit binders of NF-kappaB in Human breast cancer cells","volume":"11","author":"Ravish","year":"2023","journal-title":"Biomedicines"},{"issue":"13","key":"10.1016\/j.tranon.2025.102418_bib0020","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.3390\/molecules28135254","article-title":"Electrochemical synthesis of new isoxazoles and triazoles tethered with thiouracil base as inhibitors of histone deacetylases in Human breast cancer cells","volume":"28","author":"Vishwanath","year":"2023","journal-title":"Molecules."},{"issue":"11","key":"10.1016\/j.tranon.2025.102418_bib0021","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41417-024-00811-6","article-title":"NF-kappaB role on tumor proliferation, migration, invasion and immune escape","volume":"31","author":"Khan","year":"2024","journal-title":"Cancer Gene Ther."},{"issue":"3","key":"10.1016\/j.tranon.2025.102418_bib0022","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-005-9120-9","article-title":"Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells","volume":"97","author":"Hiscox","year":"2006","journal-title":"Breast. Cancer Res. Treat."},{"key":"10.1016\/j.tranon.2025.102418_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.592912","article-title":"Progress in the understanding of the mechanism of tamoxifen resistance in breast cancer","volume":"11","author":"Yao","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.tranon.2025.102418_bib0024","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/1541-7786.MCR-19-1082","article-title":"The NF-kappaB pathway promotes tamoxifen tolerance and disease recurrence in estrogen receptor-positive breast cancers","volume":"18","author":"Kastrati","year":"2020","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"10.1016\/j.tranon.2025.102418_bib0025","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends. Cell Biol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102418_bib0026","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10555-023-10162-7","article-title":"Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response","volume":"43","author":"Ebrahimi","year":"2024","journal-title":"Cancer Metastasis Rev."},{"issue":"7","key":"10.1016\/j.tranon.2025.102418_bib0027","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00204-021-03063-7","article-title":"Cancer drug resistance induced by EMT: novel therapeutic strategies","volume":"95","author":"De Las Rivas","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"12","key":"10.1016\/j.tranon.2025.102418_bib0028","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/ptr.5702","article-title":"Plumbagin enhances tamoxifen sensitivity and inhibits tumor invasion in endocrine resistant breast cancer through EMT regulation","volume":"30","author":"Sakunrangsit","year":"2016","journal-title":"PhytOther Res."},{"issue":"1","key":"10.1016\/j.tranon.2025.102418_bib0029","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41420-024-01888-6","article-title":"SLC26A9 promotes colorectal tumorigenesis by modulating Wnt\/beta-catenin signaling","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death. Discov."},{"key":"10.1016\/j.tranon.2025.102418_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216653","article-title":"Glutamine transporter SLC38A3 promotes breast cancer metastasis via Gsk3beta\/beta-catenin\/EMT pathway","volume":"586","author":"Tan","year":"2024","journal-title":"Cancer Lett."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:28:38Z","timestamp":1762597718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325001494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":30,"alternative-id":["S1936523325001494"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102418","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual action of pyrimidine derivatives: Targeting tamoxifen resistance in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102418","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. CCBYLICENSE","name":"copyright","label":"Copyright"}],"article-number":"102418"}}